MSC Therapeutics in Chronic Inflammation

  title={MSC Therapeutics in Chronic Inflammation},
  author={Alex Sargent and Robert H. Miller},
  journal={Current Stem Cell Reports},
The utilization of mesenchymal stem cells (also known as mesenchymal stromal cells (MSCs)) as a cell-based therapy for diseases that have ongoing inflammatory damage has become increasingly available. Our understanding of the cell biology of MSCs is still incomplete. However, as a result of increasing numbers of preclinical and clinical studies, general themes are emerging. The capacity of MSCs to reduce disease burden is largely associated with their ability to modulate the activity of the… CONTINUE READING